Amica Panja, Ashish Kumar Mishra, Mahesh Dash, Narendra Kumar Pandey, Sachin Kumar Singh, Bimlesh Kumar
Amica Panja, Ashish Kumar Mishra, Mahesh Dash, Narendra Kumar Pandey,Sachin Kumar Singh, Bimlesh Kumar
School of Pharmaceutical Sciences, Lovely Professional University, Punjab - 144411, India.
Volume - 15,
Issue - 12,
Year - 2022
Nanoparticles are solid colloidal particles which are having a size or dimensions ranging from 1-100nm.The word nano is derived from a Greek word ‘nanos’ which means extremely small, so nanoparticles are the particles that are extremely small in size. Colloidal particles are manufactured by either natural or synthetic polymers and are able to reduce toxicity, but due to certain limitation of these polymeric nanoparticles alternative carriers of lipid were formed. These alternative forms are known as Solid lipid nanoparticles (SLNs). SLNs are the novel nanoparticulate systems consisting of colloidal carriers having a size 50-100nm. In these systems basically physiological lipids are dispersed in water or in any other surfactant solutions. SLNs are made up of a solid hydrophobic core which is coated with a monolayer of phospholipid. The drug is dissolved or dispersed in a solid hydrophobic core. SLNs are able to carry lipophillic drugs with them and are able to achieve sustained release of drug. SLNs can be given via different routes. SLNs can be prepared by different methods and are characterized using SEM, TEM, DSC, TGA etc. Now SLNs are used in different aspects like in cosmaceuticals, targeting, in antitubercular chemotherapy. SLNs have different advantages like they improve the stability of pharmaceuticals, have excellent bioavailability
Cite this article:
Amica Panja, Ashish Kumar Mishra, Mahesh Dash, Narendra Kumar Pandey,Sachin Kumar Singh, Bimlesh Kumar. Solid Lipid Nanoparticles: A Promising Novel Carrier. Research Journal of Pharmacy and Technology 2022; 15(12):5879-5. doi: 10.52711/0974-360X.2022.00992
Amica Panja, Ashish Kumar Mishra, Mahesh Dash, Narendra Kumar Pandey,Sachin Kumar Singh, Bimlesh Kumar. Solid Lipid Nanoparticles: A Promising Novel Carrier. Research Journal of Pharmacy and Technology 2022; 15(12):5879-5. doi: 10.52711/0974-360X.2022.00992 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-12-86
1. Ramteke K. Joshi S. Dhole S. Solid Lipid Nanoparticles: A Review. IOSR Journal of Pharmacy, 2015; 2(6): 34-44.
2. Naseri, Neda, Valizadeh, Hadi., Zakeri, Parvin. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, preparation and application. Advanced Pharmaceutical Bulletin 2015; 5(3): 305-313.
3. Laith H. Preparation and Evaluation of Nystatin-Loaded Solid-Lipid-Nanoparticles for Topical Delivery. Asian J. Pharm 2014; 44-51.
4. Trilochan S.Prasanna K. Solid Lipid Nanoparticles: A Novel Carrier in Drug Delivery System. Research J. Pharma Dosage Forms and Tech 2013; 5(2): 56-61.
5. Amol S. Deshmukh. Solid Lipid Nanoparticles. Res. J. Pharm. Dosage Form. and Tech 2014; 6(4): 282-285.
6. Ekambaram P.,Sathali H. Abdul. K. Solid Lipid Nanoparticles: A ReviewScientific reviews and chemical communications 2012; 2(1): 80-102.
7. Mukhrjee S. Ray S. Thakur R. Solid Lipid Nanoparticles: A Modern Formulation Approach in Drug Delivery System. Indian J Pharm Science 2019; 71(4): 349-358.
8. Ashok P. Meyyanathan S. Vadivelan. Jawahar N. Nanosuspensions by Solid Lipid Nanoparticles method for the Formulation and in vitro/in vivo characterization of Nifedipine. Asian J. Res. Pharm. Sci. 2021; 11(1):1-6.
9. S. Harshavardhan Reddy, M. S. Umashankar, N. Damodharan. Formulation, Characterization and Applications on Solid Lipid Nanoparticles – A Review. Research J. Pharm. and Tech 2018; 11(12): 5691-5700.
10. Savita M. Sarika L. Vijay R. Review on Solid Lipid Nanoparticles for Ophthalmic Delivery. Res. J. Pharma. Dosage Forms and Tech.2019; 11(1):19-34.
11. Pragati S. Kuldeep S. Ashok S. Solid Lipid Nanoparticles: A Promising Drug Delivery Technology. International Journal of Pharmaceutical Sciences and Nanotechnolog 2009;, 2(2): 509-516
12. Trilochan S. Prasanna K. Solid Lipid Nanoparticles: A Novel Carrier in Drug Delivery System. Research J. Pharma. Dosage Forms and Tech. 2013; 5(2): 56-61 .
13. Siekmann, B. Westesen. K. Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions. European J. Pharm. Biopharm, 43, 104-109.
14. Kanti S. Rishita P. Naveen A. Pinkesh B. Harish S. Gyanesh S. A Review of the Novel Drug Delivery System used in the Treatment of Cancer. Res. J. Pharma. Dosage Forms and Tech 2019; 11(3):199-205.
15. Mayank S. Kamla P. Solid Lipid Nanoparticles of Simvastatin: Pharmacokinetic and Biodistribution Studies on Swiss albino mice. Research J. Pharma. Dosage Forms and Tech 2012; 4(6): 336-342.
16. Eldem T. Speiser P. Hincal A. Optimization of spray-dried and congealed lipid microparticles and characterization of their surface morphology by scanning electron microscopy Pharm Res 2009; 8: 47-54.
17. Baviskar A. Hiremath S. Akul M., Pawar P. Effect of Lipids and Surfactants on Solid Lipid Nanoparticle Engineering. Research J. Pharm. and Tech 2011; 4(4): 521-526.
18. Jain, N. K. Controlled and Novel Drug Delivery 1st Edition, (CBS Publishers and Distributors1997) 3-28.
19. Ravi G. Vishal G. Balamuralidhara V. Rivastigmine Tartrate Solid Lipid Nanoparticles Loaded Transdermal Film: An In vivo study. Research J. Pharm. and Tech. 2018; 11(1): 227-230.
20. Shenoy V.S. Vijay R.S. Tumour targeting: Biological factors and formulation advances in injectable lipid nanoparticles. Journal Pharm Pharmacology 2005; 57(23): 411-422.
21. Lu B. Xiong S.B. Yang H. Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymphnode metastases. European Journal of Pharm. Sciences 2006; 28: 86-95.
22. Santos M.C, Mehnert W. Schaller M. Drug targeting by solid lipid nanoparticles for dermal use. Journal Drug Target 2002; 10: 489-495.
23. Pandey, R., Sharma, S., Khuller, G.K.(2005). Oral SLN Based antitubercular chemotherapy, Tuberculosis (Edinb) 85, 415-420.
24. Schwarz C. Mehnert M. Solid lipid nanoparticles (SLN) for controlled drug delivery: I. Production, characterization and sterilization. Journal of Controlled Relelease 2007; 30 (7): 83-96.
25. Ruckmani K. Sivakumar M. Ganesh K. Methotrexate loaded solid lipid nanoparticles (SLN) for effective treatment of carcinoma. Journal Nano sciences Nanotechnology 2006; 6: 2991-2995.
26. Rabinarayan P. Padilama S. Production of Solid Lipid Nanoparticles-Drug Loading and Release Mechanism. Journal of Chemical and Pharmaceutical Research 2010; 2(1): 211-227.
27. Lai F. Wissing S.A. Muller, R.H. Artemisia arborescensL essential oil-loaded solid lipid nanoparticles for potential agriculture application: Preparation and characterization. AAPS Pharm Sci Tech 2006; 7: 21-27.
28. Cavalli R. Gasco M.R. Chetoni P. Burgalassi S. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. International Journal Pharm 2002; 241 – 245.
29. Rabinarayan P. Padilama S. Production of Solid Lipid Nanoparticles-Drug Loading and Release Mechanism. Journal of Chemical and Pharmaceutical Research 2010; 2(1): 211-227.
30. Rudolph C. Schillinger C. Plank C. Application of novel Solid lipid nanoparticles (SLN) - gene vector formulations based on a diametric HIV-1 VAT - peptide in vitro and in vivo.Pharmaceutic Res 2004; 21: 1662-1669.
31. Jenning V. Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. Journal of Control Release 2000; 66: 115-126.
32. Mistry S.N. Patel P.K. Bharadia P.D. Novel Drug Delivery System for Lipophilic Agents: Solid Lipid Nanoparticles. IJPI’s Journal of Pharmaceutics and Cosmetology 2011; 1(4): 76-89.
33. Maria R. Gasco. Method for producing solid lipid microspheres a narrow size distribution, Patent No US 5250236
34. Muller R. H. Lucks J.S., Arzneist offtrageraus festen Lipid teilchen, Feste Lipid nanospharen (SLN), Patent No EP 0605497
35. Kollipara Koteswara Rao. Polymerized SLN for oral or mucosal delivery of therapeutic proteins and peptides, Patent No US 20080311214A1
36. Bernd Herzog. Formulation of UV Absorbers by incorporation in SLN, Patent No US 7147841 B2
37. Maria R. Gasco., Use of SLN compromising cholesterol propionate, Patent No US 11921634
38. Ulrich Massing., Production of lipid based nanoparticles using a dual asymmetrical centrifuge, Patent No EP1838286 B1
39. Falson, Karine Padots, Fabrice., SLN encapsulating minoxidil and aqueous suspension containing same, Patent No EP2413918 A1
40. Josep, Raquel, Alfonso Kirsten., Lipid nanoparticle capsules, Patent No. EP2549977 A2
41. Westesen, Britta Siekmann., Solid lipid particles, particles of bioactive agents and method for the manufacture and use, Patent No US 5785976